Navigation Links
Inquiry H Steerable Diagnostic Catheters

ProductsInquiry H Steerable Diagnostic Catheters
Company Irvine Biomedical Inc.
Item Inquiry H Steerable Diagnostic Catheters
Features 
  • Simple, precise distal control
  • - Patented Easy-Hand steering mechanism
  • - Non-rebounding mechanism to maintain stable electrode/tissue contact
  • - 360 handle rotation for superb steering control
  • Precision handling designed to reduce procedure times
  • - Proprietary wire reinforced dual layer PEBAX shaft design
  • - Precise torqueability and pushability allow fast catheter placement and provide long-term tip stability
  • Consistent high fidelity diagnostic electrograms
  • - Platinum Iridium electrodes, Gold plated connectors, Copper conductors
  • - Produces high fidelity electrograms for easier interpretation
  • Rapid connections
  • - Quick-connect connector design
  • - Provides a single-step cable connection for faster procedures
    • Description Inquiry H Steerable Catheter. Steerable atrial mapping catheter offers a variety of designs and a unique 45 offset for catheter stability. 10 to 24 electrodes, regular and large steerable curves, inactive and active tip electrodes, and bipolar and unipolar configurations available.
    Info Irvine Biomedical Inc.
    Customer Service: (888) IBI-9876
    Web site: http://www.ibiep.com/

    Related medicine products :

    1. Inquiry Steerable Diagnostic Catheters
    2. Inquiry Fixed Curve Diagnostic Catheters
    3. Inquiry HIS Diagnostic Catheters
    4. CODMAN Steerable Neuroendoscope
    5. EPT-DX Steerable Diagnostic Catheters
    6. A-Focus Steerable Diagnostic Catheters
    7. EPT-Dx Steerable Diagnostic Catheters
    8. Polaris-DX Steerable Series
    9. Luma-Cath Lumen Diagnostic Mapping Catheters Fixed and Steerable Curves
    10. Attain Prevail™ Steerable Catheter Left-Heart Lead Delivery System
    11. Fathom Steerable Guidewire
    Other Medicine News:Health News:eDiets.com(R) Announces Q3 2008 Results 2Health News:eDiets.com(R) Announces Q3 2008 Results 3Health News:eDiets.com(R) Announces Q3 2008 Results 4Health News:eDiets.com(R) Announces Q3 2008 Results 5Health News:eDiets.com(R) Announces Q3 2008 Results 6Health News:eDiets.com(R) Announces Q3 2008 Results 7Health News:Pelvic Inflammation Puts Girls at Risk for Repeat STIs 2Health News:Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer 2Health News:Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer 3Health News:Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer 4Health News:Top NY Court Blinks in 'First Department' WPP Discrimination Power Play 2Health News:Top NY Court Blinks in 'First Department' WPP Discrimination Power Play 3Health News:Top NY Court Blinks in 'First Department' WPP Discrimination Power Play 4Health News:Top NY Court Blinks in 'First Department' WPP Discrimination Power Play 5Health News:Leading Scientists From Around the World Headed to Kansas for Symposium on Combating Deadly Infectious Diseases 2Health News: FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia – Painful Sexual Intercourse : Agency Grants New Indication for Bothersome Vaginal Symptom Associated with Menopause 2Health News: FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia – Painful Sexual Intercourse : Agency Grants New Indication for Bothersome Vaginal Symptom Associated with Menopause 3Health News: FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia – Painful Sexual Intercourse : Agency Grants New Indication for Bothersome Vaginal Symptom Associated with Menopause 4
    Breaking Medicine Technology:Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8Preventing toxic shock syndrome and other severe diseases 53247 1Got zinc 3F New zinc research suggests novel therapeutic targets 9433 1Got zinc 3F New zinc research suggests novel therapeutic targets 9433 2Recovery act funded research projects aid communities across the country 9428 1